MoneyWorks4Me

RPG Life Sciences - Quaterly Results

29 Apr 2022 Evaluate
The company witnessed a 11.90% growth in the revenue at Rs. 1038.00 millions for the quarter ended March 2022 as compared to Rs. 927.60 millions during the year-ago period.The Company has registered profit of Rs. 75.20  millions for the quarter ended March 2022, a growth of 8.67%  over Rs. 69.20 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 147.70 millions from 129.60 millions in the quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1038.00 927.60 11.90 4401.60 3891.40 13.11 4401.60 3891.40 13.11
Other Income 12.60 3.00 320.00 29.90 9.10 228.57 29.90 9.10 228.57
PBIDT 147.70 129.60 13.97 893.50 708.40 26.13 893.50 708.40 26.13
Interest 0.60 0.90 -33.33 5.20 7.90 -34.18 5.20 7.90 -34.18
PBDT 147.10 128.70 14.30 888.30 700.50 26.81 888.30 700.50 26.81
Depreciation 37.80 39.20 -3.57 156.60 164.70 -4.92 156.60 164.70 -4.92
PBT 109.30 89.50 22.12 731.70 535.80 36.56 731.70 535.80 36.56
TAX 34.10 20.30 67.98 216.90 135.80 59.72 216.90 135.80 59.72
Deferred Tax -6.90 -9.20 -25.00 -10.70 -35.70 -70.03 -10.70 -35.70 -70.03
PAT 75.20 69.20 8.67 514.80 400.00 28.70 514.80 400.00 28.70
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 14.23 13.97 1.85 20.30 18.20 11.51 20.30 18.20 11.51
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..